Among them, the HER2 in-frame 766–779 YVMA insertion (HER2 InsYVMA), which is frequently detected in NSCLC [112], induces constitutive activation of this receptor, resulting in downstream signaling activation independently of EGFR [113]. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.